ArticleJournal of endocrinological investigation2010

Patients affected by vitiligo and autoimmune diseases do not show antibodies interfering with the activity of the melanocortin 1 receptor.

P Agretti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.